Orion Group's Financial Statement documents for 2025 have been published. The documents are available in Finnish and English on the Company's website at https://www.orionpharma.com and are attached to ...

FARMINGTON, Utah--(BUSINESS WIRE)-- PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it will restate its previously issued condensed combined/consolidated financial ...

Digitalist Group’s Financial Statements 2025 will be published and posted on the company's website on 27 March 2026. Digitalist Group Plc’s Financial Statements will be published in Finnish and ...

Highlights: Fourth quarter intermodal volume increased 1% from prior year Strong year-end balance sheet with cash and restricted cash of ...

"Year 2023 was another eventful year for Orion, with the most significant achievements being the progress of the clinical development pipeline and the strong growth of Nubeqa®. We also continued to ...

This document may contain statements that are predictive or otherwise forward-looking in nature, that depend upon or refer to future events or conditions, or that include words such as “may”, “will”, ...

"In October–December 2025, our net sales increased by 60.1 percent to EUR 695.3 (434.4) million and operating profit increased more than threefold to EUR 328.1 (92.7) million. Underlying business ...

Revenue for the second half of 2025 increased to EUR 64.2 (H2/2024: 57.2) million; Speciality Alloys processed material sold increased by 32.7%, to 13,053 (H2/2024: 9,837) tonnes; Tonnage mined ...

For investors, a company's financial statements offers insight into the health of the company. Depending on the size of a company and the complexity of its business, the financial statements may be a ...

Turnover: EUR 4.1 million (EUR 4.7 million), change -11.9%. EBITDA: EUR -0.0 million* (EUR -0.2 million), -0.9% of turnover (-4.3%). EBIT: EUR -0.2 million* (EUR -0.3 ...